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We aimed to examine the growth suppressive effects of quercetin on acute promyelocytic and
lymphoblastic leukemia and chronic myeloid leukemia, and to find out whether the growth suppression
is related to the blocking of telomerase enzyme activity. Cytotoxic effects of quercetin were shown by
trypan blue analyses. Apoptotic effects of quercetin were examined by acridine orange and ethidium
bromide staining by fluorescence microscopy. The effects of quercetin on telomerase enzyme activity were
shown by hTERT Quantification Kit. Our results demonstrated that quercetin has antiproliferative and
apoptotic effects on T-cell acute lymphoblastic leukemia (ALL), acute promyelocytic leukemia, and chronic
myeloid leukemia (CML) cells. We also showed for the first time by this study that quercetin suppresses the
activity of telomerase in ALL and CML cells. The results of this study show the importance of quercetin for
its therapeutic potential in treatment of leukemias.
Keywords: Quercetin, hTERT, Telomerase, Apoptosis, Leukemia
Introduction
Flavonoids are naturally occurring polyphenolic com-
pounds found widely in roots, stems and flowers of
grains, fruits, and vegetables. Although initially they
were not thought to have functions besides pigmenta-
tion, increasingly studies have revealed that flavonoids
are involved in numerous physiological processes in
plants. Flavoring of food plants,1 antifungal and
bactericidal protection,2 protection from ultraviolet
radiation,3 and regulation of plant growth4 are among
the processes in which flavonoids have importance. An-
tioxidative protection is one of the most important
features of flavonoids.5 Additionally, flavonoids exert cli-
nically relevant anti-atherosclerotic,6 anti-inflammatory,7
anti-thrombogenic,8 and anti-viral9 effects.
Quercetin is a member of the flavones subgroup of
the flavonoids, and it is prevalently found in black
and green tea, red onion, broccoli, and tomato.10 This
compound has antioxidant properties and it is espe-
cially known for its iron-chelating characteristics.11
Quercetin has been shown to have beneficial effects on
health such as reduction of the risks of coronary artery
disease,12 lung cancer,13 asthma,14 and disruption of
pulmonary functions.15 It is also known to have anti-
inflammatory effects through inhibition of cytokines,
such as TNF-alpha and IL8.16,17 This compound is
also potent for inhibiting melanoma growth18 and
angiogenesis.19 Because of those properties, quercetin
deserves further research to delineate its possible usage
as an antineoplastic agent in various cancers.
Leukemias are cancers of blood-forming tissues. As
in other types of cancer, blood forming progenitor cells
undergo uncontrolled cell proliferation in leukemias
and interfere with the normal functioning of the circu-
latory system. Three leukemic cell lines used in this
study represent three different types of leukemia. The
first of these is chronic myeloid leukemia (CML) which
is the first leukemia where its progression is docu-
mented to be caused by a chromosomal translocation.20
Reciprocal translocation between chromosomes 9 and
22 producing the Philadelphia chromosome is the main
driving force of the malignant transformation since it
causes constitutive expression of an aberrant tyrosine
kinase, BCR–ABL fusion protein.21 The second
leukemia type involved in the current study is acute
Correspondence to: Yusuf Baran, Department of Molecular Biology and
Genetics, Faculty of Science, Izmir Institute of Technology, Gulbahce
Campus, 35430 Urla, Izmir, Turkey. Email: yusufbaran@iyte.edu.tr
 W. S. Maney & Son Ltd 2011
DOI 10.1179/102453311X13085644680104 Hematology 2011 VOL. 16 NO. 5 303
promyelocytic leukemia (APL) which is a subtype of
acute myelogenous leukemia. In the majority of the
APL cases, retinoic acid receptor-alpha gene on the
chromosome 17 undergoes a reciprocal translocation
with promyelocytic leukemia gene on the chromosome
15.22 The third and the last type of the leukemia within
the scope of this study is acute lymphoblastic leukemia
(ALL). While the exact causes of ALL are not known,
some genetic and chromosomal aberrations and
epigenetic changes are found in the leukemic cells that
might disrupt the cellular signaling pathways and
transcription factors.23–26 Chemotherapy and radio-
therapy for the increased burden of the leukemic cells
are the current options for the ALL therapy.27
Telomeres are the repeat sequences found at the ends
of chromosomes which protect against the replicative
loss of the genetic information occurring each time the
cell replicates its DNA. This loss is an inevitable
outcome of the DNA replication machinery which
cannot synthesize the daughter DNA strand fully at the
farthermost ends. Integrity of the telomeres was shown
to be affected by the oxidative stress in addition to the
end-replication problem.28 Deterioration of the telo-
meres is thought to be responsible for the limited
capacity of replication of the cell under in vitro
conditions.29 However, cancer cells maintain the ability
of limitless replication potential by re-activating the
telomerase enzyme which prevents shortening of the ends
of chromosomes by adding more repetitive sequences.30
Telomerase composed of a reverse transcriptase
(hTERT in humans) and an RNA component which
would be used as the template for elongation of the
telomeric DNA. Activation of this enzyme is one of the
hallmarks of cancer31,32 and suppression of this ability
might provide effective means to fight with cancer.
In the current study, we aimed to investigate
quercetin-dependent apoptotic induction and inhibi-
tion of leukemic cell proliferation, and the effects of
quercetin on telomerase activity.
Materials and Methods
Leukemic cell lines and chemical reagents
CCRF-CEM human T-cell acute lymphoblastic leuke-
mia, HL-60 human acute promyelocytic leukemia, and
K-562 human chronic myeloid leukemia cells were used
as model systems in this study which was obtained
from ATCC (Manassas, VA, USA). Quercetin was
obtained from Sigma Chemical Co. (St Louis, MO,
USA). The chemicals were diluted in 0.5% dimethyl-
sulphoxide. Cell proliferation assay (XTT) was sup-
plied from Roche Diagnostics (Munchen, Germany).
LightCycler Telo TAGGG hTERT Quantification Kit
was obtained from Roche Applied Science (Mann-
heim, Germany) for the quantification of hTERT
mRNA. All other tissue culture supplies were obtained
fromCorning Incorporated (Corning, NY, USA) unless
specified otherwise.
Assessment of cytotoxicity
All leukemia cells were incubated at the density of
56105 cells/ml in RPMI-1640 medium containing
2 mM L-glutamine supplemented with 10% inacti-
vated fetal bovine serum and 1% penicillin/strepto-
mycin in a standard cell culture incubator at 37uC,
under humidified 95% air, and 5% CO2 atmosphere.
33
Before each experiment, cells were split at 56105
cells/ml in the RPMI 1640 medium and cell suspen-
sions was aliquoted into flasks for subsequent
treatments. Quercetin diluted in RPMI-1640 was
used in treatments of 12.5, 25, 50, 75, and 100 mM.
Cytotoxicity effects of quercetin on leukemia cells
were determined by using trypan blue dye exclusion
as indicated in manufacturers’ instructions.
Morphological evaluation of apoptosis using
acridine orange/ethidium bromide staining
Apoptosis was determined morphologically after
staining with acridine orange and ethidium bromide
by fluorescence microscopy. Cells were washed with
cold phosphate-buffered saline and adjusted to the
cell density of 16106 cells/ml in phosphate-buffered
saline. Acridine orange and ethidium bromide (1 : 1)
(v/v) were added to the cell suspension in final
concentrations of 100 mg/ml and then cells were
incubated for 30 min. The cellular morphology was
evaluated by fluorescent microscopy (Olympus,
Tokyo, Japan). Apoptotic cells were essentially
characterized by nuclear condensation of chromatin
and/or nuclear fragmentation. Three hundred cells
were evaluated for apoptosis and/or necrosis for each
sample. When more than 50% of the pre-apoptotic
plus apoptotic to total cell ratios were positive, the
result was accepted positive for apoptosis.
Determination of hTERT activity
Total RNA was isolated from the leukemia cells
treated with increasing concentrations of quercetin
for 48 and 72 hours and, hTERT mRNA quantifica-
tion was performed with commercially available
LightCycler TeloTAGGGG hTERT Quantification
Kit (Roche Applied Science) using the LightCycler
instrument for real-time PCR. All subsequent quan-
tification steps were carried out according to manu-
facturer’s instructions.
Results
Quercetin decreases cell viability of leukemic cell
lines in a time- and dose-dependent manner
Leukemic cell death upon treatment with quercetin
was assessed by the trypan blue staining. Time- and
dose-dependent decrease patterns were found in the
viability of all the three leukemic cell lines (Fig. 1).
K562 cells showed a more gradual survival curve
than the CCRF-CEM and HL60 cells at 48 hours,
but at 72 hours, K562 cells had the steepest decrease
Avci et al. Quercetin-induced apoptosis in leukemia
304 Hematology 2011 VOL. 16 NO. 5
in the survival. Increasing concentrations of quercetin
is linked to the increased cell death in leukemic cells.
Evaluation of apoptotic induction
Treatment of the leukemic cells with quercetin
decreased the viability and increased the apoptotic
and necrotic cell death in a dose-dependent manner
(Fig. 2) in each cell line. This observation was valid
for all of the tested time periods which are 24, 48, and
72 hours. While increasing concentration of quercetin
decreased the ratio of viable cells in all three of the
leukemic cell lines, treatment duration of quercetin
did not appear to have a significant contribution to
the apoptosis and necrosis. When the results are
examined at the constant concentration of quercetin
over the time periods, it appears that quercetin had
higher potential of time-dependent suppression on
CCRF-CEM and HL60 cells compared to the K562
cells, since K562 cells did not undergo apoptosis and
necrosis in the increasing amounts over the tested
time periods at the constant concentration of
quercetin. In each of the three leukemic cell lines,
ratio of the necrotic cells was found to be less than
the ratio of the apoptotic cells. Ratio of the necrotic
cells reached at most 22%, whereas the ratio of
apoptotic cells was around 60% at maximum values.
Determination of hTERT activity
Telomerase activity in the CCRF-CEM and K562
cell lines demonstrated decreasing patterns with the
increasing concentrations of quercetin (Fig. 3).
However, telomerase activity of HL60 cells remained
relatively constant with insignificant amounts of
increases in the presence of the increasing amounts
of quercetin. Time-dependent suppression of hTERT
activity is more apparent in CCRF-CEM cell line
compared to the others.
Discussion
The effects of quercetin on leukemic cell death were
investigated in the current study. When examined
generally, results indicate that extent of cell death is
proportional to the quercetin concentration in three
leukemia cell lines. Cytotoxicity is assessed by the
trypan blue exclusion assay in which living cells actively
pump the dye out, while the dead cells remained
stained. Counting the number of those cells gave an
approximation about the cytotoxicity of the quercetin.
Experimentations in 48 and 72 hours demonstrated
slightly different survival plots in CCRF-CEM and
HL60 cells. When results at the end of 48 hours are
examined, it is apparent thatK562 cells are less sensitive
to the quercetin compared to the other cells. But all of
the three cell lines have similar plots in 72 hours.
Survival of HL60 and K562 cells are suppressed by
more than 90% in 12.5 mM of quercetin, whereas
CCRF-CEM cells seem to be less sensitive to the same
concentration since 65% of the cells are killed in
72 hours. Remaining data points of CCRF-CEM cells
showed higher number of surviving cells as well
compared to the HL60 and K562 cells, indicating that
CCRF-CEM cells might be less sensitive to quercetin.
Quercetin was shown to induce apoptosis and
necrosis in CML, APL, and ALL cell lines by this
study. However, apoptotic induction appears to be
more important than the necrosis in the cytotoxicity
of quercetin since the amount of necrotic cells showed
minor changes unlike the amount of apoptotic cells.
Increasing concentrations of quercetin is in accor-
dance with the decreasing amounts of cellular
viability in each cell line; but this explicit trend is
not observable when the results of the experiments
involving similar concentrations of quercetin are
examined over different time periods, especially for
the K562 cells. This may show that quercetin might
be reaching full functionality as soon as the 48 hours
of treatment, and therefore, the results at the 48 and
72 hours might not be varying much.
Assessment of hTERT activity in three leukemic
cell lines showed varying results. Telomerase activity
remains unaffected by the presence of quercetin in
Figure 1 Effects of quercetin on cell viability of leukemia
cells. Cytotoxic effects of Quercetin on CCRF-CEM (A), HL60
(B), and K562 (C) cells were examined by trypan blue dye
exclusion assay for 48 and 72 hours.
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HL60 cells, though there was a slight dose-dependent
increase which is seemingly not very significant. On
the other hand, CCRF-CEM and K562 cells showed
time- and dose-dependent decreases in telomerase
activity. This difference might be indicative of the
distinct nature of malignancy of HL60 cells (APL
cells) compared to the CCRF-CEM and K562 cells
(ALL and CML cells, respectively). Despite the
constant hTERT activity, quercetin is still cytotoxic
to the HL60 cells as it is to the other two cell lines.
This fact might suggest that, for at least APL cells,
quercetin exerts its tumor suppressive effects through
a telomerase-independent pathway.
The results of this study might be useful for
attributing new roles to quercetin for the treatment
of different types of leukemias. Quercetin was
previously shown to suppress tumor growth in various
experimental set-ups.18,19,34 The current study pro-
vides evidence of its potential for use in the treatment
of leukemia. Despite advances in therapeutic out-
comes in leukemia cases, development of resistance to
known chemotherapeutic agents and, therefore, the
lack of a definitive cure, pushes scientists forward to
look for new therapeutic options and chemotherapy
agents. Quercetin may prove to be an important
compound in this research since it has cytotoxic effects
on the leukemic cell lines. However, the findings of this
study must be tested further in animal systems to
reveal the actual physiological feasibility of its use in
Figure 2 Apoptotic and necrotic effects of quercetin on CCRF-CEM (A), HL60 (B), and K562 (C) cells were examined by using
acridine orange/ethidium bromide staining for 48 and 72 hours.
Figure 3 Effects of quercetin on hTERT mRNA levels.
Expression levels of hTERT were determined by qPCR in
CCRF-CEM (A), HL60 (B), and K562 (C) cells treated with
increasing concentrations of quercetin for 48 and 72 hours.
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leukemia therapeutics. Along with further evidence
supporting the findings of the current study, querce-
tin might be incorporated in the future therapeutic
options for leukemia.
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